Loading clinical trials...
Loading clinical trials...
A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects With Parkinson's Disease
Conditions
Interventions
Ketamine
Midazolam
Locations
7
United States
Investigative Site #7
Tucson, Arizona, United States
Investigative Site #2
Chula Vista, California, United States
Investigative Site #1
Fountain Valley, California, United States
Investigative Site #3
Miami, Florida, United States
Investigative Site #6
Miami, Florida, United States
Investigative Site #5
Rolling Meadows, Illinois, United States
Start Date
October 5, 2021
Primary Completion Date
December 30, 2023
Completion Date
March 30, 2024
Last Updated
November 18, 2023
NCT05386108
NCT06821230
NCT05508789
NCT00001208
NCT07428447
NCT06954610
Lead Sponsor
PharmaTher Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions